You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence
Discover Care Believe - boy on pier 

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

What do you #DiscoverCareBelieve? 

Minor gene mutations can produce extensive disruption of protein interactions, study finds

April 23, 2015

In a new study, researchers at Dana-Farber Cancer Institute show that disruptions to the activity of cell proteins can reveal which genetic mutations lead to disease and which are mere bystanders.

patient and doctor 

New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women'’s Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

Dana-Farber researcher awarded prestigious European scientific prize
April 24, 2015

Bruce Spiegelman, PhD, Dana-Farber Cancer Institute, has received Belgium's most important international scientific prize for his contributions to understanding the mechanisms of metabolic disorders.

Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health and Irish Cancer Society join to advance cancer research
April 23, 2015

Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health in Boston and the Irish Cancer Society have formed the Boston-Ireland Prostate Cancer Collaboration. This new entity will conduct and facilitate exchanges of researchers and knowledge between Boston and Ireland.

Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes
April 21, 2015

Dana-Farber researchers report that combination treatment with olaparib and BKM120 was safe and yielded evidence of clinical benefit for women with triple-negative breast cancer and for those with high-grade serous ovarian cancer in a phase I clinical trial.

Eating on Chemo: Tips to Overcome Taste and Weight Challenges (USNews)

April 27, 2015

Dana-Farber nutritionist Stacy Kennedy, MPH, discussed the importance of maintaining good nutrition for cancer patients.

My First Male Mammogram (
April 27, 2015

Dr. Judy Garber discussed breast cancer among men and the lack of awareness despite a surge in news surrounding the BRCA gene.

Many Breast Cancer Patients Still Opt for Mastectomy Over Lump Removal (WBZ-TV)
April 24, 2015

Dr. Mehra Golshan led a study that shows many patients are opting for a mastectomy despite the high success rates a lumpectomy can offer.

Bristol-Myers Drug Combination Shows Promise Against Melanoma (Wall Street Journal)
April 21, 2015

Dr. F. Stephen Hodi co-led a study that found combining two drugs that unleash the immune system to attack cancer was significantly more effective in stifling tumors in melanoma patients than using just one of the treatments alone.

E-cigarette battle heats up (Harvard Gazette)
April 17, 2015

K. "Vish" Viswanath, PhD was a panelist for a discussion titled "Can E-cigarette Regulation Protect the Public’s Health? Making Sense of the Science."

Seeking Ways to Improve Cancer Care for Children, Adolescents, and Young Adults (Oncology Times)
April 17, 2015

Dr. Joanne Wolfe commented on the pressing need for improvements in the care of pediatric cancer patients, despite research showing increased survival rates in the group.

Promising drug target identified in medulloblastoma (Oncology Nurse Advisor)
April 13, 2015

Dr. Rosalind Segal led a study that identified a protein critical to both the normal development of the brain and the development of medulloblastoma, a fast-growing brain tumor that usually strikes children younger than 10.

Dana-Farber's Mammography Van(20)

April 28, 2015

Bowdoin Street Health Center

Dana-Farber’s Mammography Van brings state-of-the-art breast cancer screening to the women of Greater Boston. To learn more or schedule an appointment, please call 617-632-1974. Visit is on the Web at

Dana-Farber’s Mammography Van is managed by Dana-Farber Cancer Institute’s Mobile Health program and possesses a valid license and certificate of inspection issued by the Massachusetts Department of Public Health.

Tai Chi for Optimal Health

April 28, 2015

3:00 PM - 4:30 PM

Smith Room, 330, Stoneman Patient Services Suite

An internal Chinese martial art practiced for both defense training and health benefits. Learn sitting and standing techniques as well as slow moving meditation. Open to patients and family members. Please register at 617-632-3322. more

Sunset Qigong

April 28, 2015

4:30 PM - 6:00 PM

Smith Room 330, Stoneman Patient Services Suite

Fine tune your mind/body skills and create balance among them. Open to patients and family members. Please register at 617-632-3322. more

  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    Quick access: Appointments as soon as the next day for new adult patients

    For children:

    Request Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button 
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2014-2015 logo    U.S. News Best Children's Hospitals Cancer 2014-2015 logo 

    Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now